Subcutaneous ICD effective at VT/VF conversion, with few inappropriate shocks
FROM CIRCULATION
The early treatment also was associated with a significantly lower proportion of any intracranial hemorrhage (14.8% vs. 17.6%) and a nonsignificantly lower proportion of symptomatic intracranial hemorrhage (3.7% vs. 4.5%).
Early treatment was not associated with mortality – a finding contrary to the authors’ prior study. "This may be because of the limited number of patients treated ultra-early in the current cohort," they said.
Dr. Weiss reported no financial disclosures, but 10 of the 19 coauthors did report multiple relationships with pharmaceutical companies. Dr. Weiss and eight of the 11 coauthors are consultants for Cameron Health. Three have received research grants from the company. Dr. Weiss and three of the coauthors are consultants for and have received research grants from Boston Scientific or Cameron Health.
On Twitter @Alz_Gal
